Cannabis and Abn-CBD
Browse the latest research linking medical marijuana / medicinal cannabis and Abnormal Cannabidiol (Abn-CBD) (a cannabinoid (synthetic))

Abnormal cannabidiol (Abn-CBD) is a synthetic regioisomer of cannabidiol, which unlike most other cannabinoids produces vasodilator effects, lowers blood pressure, and induces cell migration, cell proliferation and mitogen-activated protein kinase activation in microglia, but without producing any psychoactive effects. [Wikipedia]
Click on a study title below to open a new tab with full article, or click on a compound to see it's full list of research.
Compounds Topics Title Date
O-1602,Abn-CBD diabetes in mice via experiment G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic beta--cells Apr 2019
Action Pathway: GPR55
Our results demonstrated that O-1602 and Abn-CBD increased glucose-induced insulin secretion in MIN6 cells, which was abolished by a PLC inhibitor, U73122.
Back to Knowledge Base